Brief: Ose Immunotherapeutics Provides Covid-19 Vaccine Update On Covepit

Ose Immunotherapeutics SA

05/11/2020 17:17

Nov 5 (Reuters) - Ose Immunotherapeutics SA  OSE.PA :
    * OSE IMMUNOTHERAPEUTICS PROVIDES COVID-19 VACCINE UPDATE ON
COVEPIT, ITS MULTI-TARGET AND LONG-LASTING VACCINE CANDIDATE
    * PRIMARY OBJECTIVE ACHIEVED IN HUMAN EX VIVO STUDY
    * CLINICAL TRIAL EXPECTED TO START IN Q1 2021
    * NEW CORONAVIRUS MUTATED VARIANTS STRENGTHEN MULTI-EPITOPE
T
LYMPHOCYTES VACCINE VERSUS 11 VIRAL PROTEINS APPROACH

Source text for Eikon:  ID:nBw29hdTJa 
Further company coverage:  OSE.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))